ArticleCancers2025

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.